404 filings
Page 2 of 21
6-K
KMDA
Kamada Ltd
30 Aug 23
Kamada Announces Shareholder Approval and Planned Closing of $60 Million Private Placement with FIMI Opportunity Funds
7:00am
6-K
KMDA
Kamada Ltd
16 Aug 23
Report of Foreign Private Issuer
7:00am
6-K
KMDA
Kamada Ltd
9 Aug 23
Report of Foreign Private Issuer
7:00am
6-K
KMDA
Kamada Ltd
13 Jul 23
Notice of Extraordinary General Meeting of Shareholders
4:05pm
6-K
KMDA
Kamada Ltd
12 Jul 23
Report of Foreign Private Issuer
7:00am
SC 13D/A
KMDA
Kamada Ltd
24 May 23
KAMADA / DAVIDI ISHAY ownership change
4:50pm
6-K/A
KMDA
Kamada Ltd
24 May 23
Current report (foreign) (amended)
4:05pm
6-K
KMDA
Kamada Ltd
24 May 23
Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates
8:00am
6-K
KMDA
Kamada Ltd
24 May 23
Report of Foreign Private Issuer
7:05am
6-K
KMDA
Kamada Ltd
24 May 23
Kamada Announces $60 Million Private Placement with FIMI Opportunity Funds
7:00am
6-K
KMDA
Kamada Ltd
17 May 23
Report of Foreign Private Issuer
7:00am
6-K
KMDA
Kamada Ltd
16 May 23
Kamada Announces Receipt of Marketing Authorization for Glassia® for Treatment of Alpha-1 Antitrypsin Deficiency in Switzerland
7:00am
6-K
KMDA
Kamada Ltd
3 May 23
Kamada Announces U.S. FDA Approval of its Application to Manufacture CYTOGAM® at the Company’s Facility in Israel
7:00am
6-K
KMDA
Kamada Ltd
15 Mar 23
Kamada Issues 2023 CEO Letter to Shareholders
7:18am
6-K
KMDA
Kamada Ltd
15 Mar 23
Report of Foreign Private Issuer
7:16am
20-F
2022 FY
KMDA
Kamada Ltd
Annual report (foreign)
15 Mar 23
7:14am
6-K
KMDA
Kamada Ltd
15 Mar 23
Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results, and Provides 2023 Guidance Representing Significant Profitability Growth
7:10am
6-K
KMDA
Kamada Ltd
9 Mar 23
Report of Foreign Private Issuer
8:17am
SC 13G/A
PXGPE
Phoenix Group Corp
14 Feb 23
KAMADA / Phoenix ownership change
4:29pm
6-K
KMDA
Kamada Ltd
4 Jan 23
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
7:00am